Elimination of blinding trachoma

Current Opinion in Infectious Diseases

Volumn 15, Issue 5, 2002, Pages 491-495

  Schachter, Julius ^a   Dawson, Chandler R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blindness; Chlamydia trachomatis; Trachoma

Indexed keywords

AZITHROMYCIN; ERYTHROMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; BLINDNESS; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUSTRY; DRUG MECHANISM; ENDEMIC DISEASE; ENVIRONMENTAL MANAGEMENT; EYELID; GENITAL TRACT INFECTION; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; HYGIENE; INFECTION CONTROL; PREVALENCE; PUBLIC HEALTH; REVIEW; TRACHOMA; TREATMENT INDICATION;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHLAMYDIA TRACHOMATIS; HUMANS; HYGIENE; PUBLIC HEALTH; TRACHOMA;

EID: 0036791319     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200210000-00006     Document Type: Review

References (25)

1. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ 1995; 73:115-121.
2. Lewallen S, Courtright P. Blindness in Africa: present situation and future needs. Br J Ophthalmol 2001; 85:897-903.
3. Hsieh YH, Bobo LD, Quinn TC, West SK. Determinants of trachoma endemicity using Chlamydia trachomatis ompA DNA sequencing. Microbes Infect 2001; 3:447-458.
4. West SK, Munoz B, Mkocha H, et al. Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol 2001; 8:137-144.
5. Bowman RJ, Jatta B, Cham B, et al. Natural history of trachomatous scarring in The Gambia: results of a 12-year longitudinal follow-up. Ophthalmology 2001; 108:2219-2224.
6. Pruss A, Mariotti SP. Preventing trachoma through environmental sanitation: a review of the evidence base [Review]. Bull World Health Organ 2000; 78:258-266.
7. Emerson PM, Cairncross S, Bailey RL, Mabey DC. Review of the evidence base for the 'F' and 'E' components of the SAFE strategy for trachoma control [Review]. Trop Med Int Health 2000; 5:515-527.
8. Reinhards J, Weber A, Nizetic B, et al. Studies in the epidemiology and control of seasonal conjunctivitis and trachoma in southern Morocco. Bull World Health Organ 1968; 39:497-545.
9. Hsieh YH, Bobo LD, Quinn TO, West SK. Risk factors for trachoma: 6-year follow-up of children aged 1 and 2 years. Am J Epidemiol 2000; 152:204-211.
10. Dawson CR, Jones BR, Tarizzo ML. A guide to trachoma control. Geneva: World Health Organization; 1981.
11. Taylor HR, Siler JA, Mkocha HA, et al. The natural history of endemic trachoma: a longitudinal study. Am J Trop Med Hyg 1992; 46:552-559.
12. Centers for Disease Control and Prevention. Sexually transmitted diseases: treatment guidelines 2002. MMWR 2002; 51:1-82.
13. Malaty R, Zaki S, Said ME, et al. Extraocular infections in children in areas with endemic trachoma. J Infect Dis 1981; 143:853.
14. Bailey RL, Arullendran P, Whittle HC, Mabey DC. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet 1993; 342:453-456.
15. Dawson CR, Schachter J, Sallam S, et al. A comparison of oral azithromycin with topical oxytetracycline/polymyxin for the treatment of trachoma in children. Clin Infect Dis 1997; 24:363-368.
16. Bowman RJ, Sillah A, Van Dehn C, et al. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. Invest Ophthalmol Vis Sci 2000; 41:4074-4079.
17. Schachter J, West S, Mabey D, et al. Azithromycin in control of trachoma. Lancet 1999; 354:630-635.
18. International Trachoma Initiative. www.trachoma.org.
19. Khandekar R, Mohammed AJ, Courtright P. Recurrence of trichiasis: a long-term follow-up study in the Sultanate of Oman. Ophthalmic Epidemiol 2001; 8:155-161.
20. Emerson PM, Bailey RL, Mahdi OS, et al. Transmission ecology of the fly Musca sorbens, a putative vector of trachoma. Trans R Soc Trop Med Hyg 2000; 94:28-32.
21. Emerson PM, Bailey RL, Walraven GE, Lindsay SW. Human and other faeces as breeding media of the trachoma vector Musca sorbens. Med Vet Entomol 2001; 15:314-320.
22. Diamant J, Benis R, Schachter J, et al. Pooling of Chlamydia laboratory tests to determine the prevalence of ocular Chlamydia trachomatis infection. Ophthalmic Epidemiol 2001; 8:109-117.
23. Frick KD, Lietman TM, Holm SO, et al. Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children. Bull World Health Organ 2001; 79:201-207.
24. Laming AC, Currie BJ, DiFrancesco M, et al. A targeted, single-dose azithromycin strategy for trachoma. Med J Aust 2000; 172:163-166.
25. Lietman T, Porco T, Dawson C, Blower S. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat Med 1999; 5:572-576.